Pharmaceuticals and CROs Tool Up for Smarter Clinical Trials

Share Article

Adoption by industry leaders of FACTS™ confirms product’s status as top tool for advance study design

Adaptive Clinical Trials

FACTS™ provides access to better phase 1 and phase 2 trial designs, that can save millions of dollars in phase 2 drug development, and make better choices of the dose to test in phase 3.

Tessella, the international provider of science powered technology and consulting services and Berry Consultants, leaders in the Bayesian approach to medical statistics announce that a major global pharmaceutical company and a leading CRO have both licensed FACTS™ to augment their trial design capability.

After a thorough evaluation of the FACTS™ clinical trial design and simulation system, both companies will join the growing community of FACTS™ users, which includes other major global pharmaceutical organisations and more recently Aptiv Solutions. The use of FACTS™ software will enable these companies to rapidly evaluate a range of advanced statistical approach when designing trials, and it will give them access to a growing range of novel and leading edge trial design ideas.

Tessella and partners, Berry Consultants, have over 10 years experience of helping clients design, simulate and execute adaptive clinical trials across many therapeutic areas.

The FACTS™ 2 clinical trial design and simulation software is a fully supported, commercialized package that brings some of the most commonly used features of advanced trial designs straight to the statistician’s computer with a powerful user interface. The tool allows a rapid stepwise design of both fixed and adaptive trials. Its enables biostatisticians to easily select between options and rapidly simulate multiple scenarios so that different design features can be evaluated, optimal parameter settings found and the expected performance of the planned trial explored.

FACTS™ provides access to better phase 1 and phase 2 trial designs, that can save millions of dollars in phase 2 drug development, and make better choices of the dose to test in phase 3.

Notes to the Editor

About Tessella

Founded in 1980, Tessella is the international provider of science powered technology and consulting services. World leading organizations choose our unique blend of science, engineering and sector expertise to deliver innovative and cost-effective solutions to complex real-world commercial and technical challenges. Our people are high achievers from leading universities and are passionate about delivering value to clients.

For further information visit our dedicated website on http://www.smarterclinicaltrials.com

About Berry Consultants

Berry Consultants is a statistical consulting group specializing in adaptive clinical trial design in pharmaceutical and medical device research and development.

For further information visit our website on http://www.berryconsultants.com/

Media Contacts
Tessella
Christina Tealdi | Senior PR and Communications Manager
Phone: +44 (0) 1235 555511 | Mobile: + 44 (0) 779 9346453 | christina.tealdi(at)tessella(dot)com

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Christina Tealdi
Visit website